Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2025-03-06 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-03-06 English
Initial Director's Interest Notice 2 pages 270.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of a newly appointed director, including unlisted options and restricted stock units. This type of document is a report of personal share transactions or holdings by a company director. It is not an annual report, earnings release, or any other financial report. It fits the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a broader financial or regulatory filing.
2025-03-06 English
Director Appointment/Resignation 3 pages 229.5KB
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 6 March 2025 regarding the appointment of David St Denis as the Company President and a non-independent director of the Board. It details his background, terms of employment, and confirms no changes to compensation arrangements. The document references compliance with ASX Listing Rule 3.16.4 and includes an annexure summarizing material employment terms. There are no financial statements, earnings data, or detailed management discussion of financial results. The content focuses solely on a change in senior management and board composition. Therefore, this document fits the category of Board/Management Information (MANG). The document length (7,621 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-03-05 English
Application for quotation of securities - AVR 8 pages 21.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from Anteris Technologies Global Corp. It details the application for quotation of securities on the ASX, specifically securities issued or converted from options being exercised. The document includes information about the number and type of securities to be quoted, issue dates, and issued capital following quotation. This type of document is a formal application to list or quote new securities on the exchange, which corresponds to announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about securities quotation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (7206 characters) and content confirm it is not merely a brief announcement or a report publication notice but a detailed application form for securities quotation.
2025-03-04 English
Statement of CDIs on issue - AVR 5 pages 19.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and contains detailed monthly data on the number and class of CHESS Depositary Interests (CDIs) and other securities issued by Anteris Technologies Global Corp. It includes changes in securities issued, transfers between CDIs and common stock, and option details with expiration dates and exercise prices. The document is dated March 5, 2025, and reports data for February 2025. The content is a regulatory announcement related to securities on issue, typical of Appendix 4A filings on the ASX, which are used to report changes in securities issued and capital structure. It is not a financial report, earnings release, or management discussion, nor is it a proxy, AGM material, or legal proceeding. It is a regulatory announcement about securities issued and changes in capital structure but does not detail financing activities or fundraising per se. Given the nature of the document as a formal securities issuance statement under ASX rules, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-03-04 English
ASX waiver from requirement to lodge an Appendix 4E 2 pages 189.7KB
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a waiver granted by the ASX to the company Anteris Technologies Global Corp. from the requirement to lodge an Appendix 4E. It discusses the terms of the waiver, specifically that the company will provide its Annual Report on Form 10-K to the ASX. The document does not contain any financial statements or substantive financial data itself, nor is it the actual Form 10-K or Annual Report. It is a regulatory announcement about compliance and reporting obligations. The document length is 3682 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-27 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.